Interstitial lung disease: Raising the index of suspicion in primary care

npj Primary Care Respiratory Medicine

Volumn 24, Issue , 2014, Pages

  Zibrak, Joseph D ^a   Price, David ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PIRFENIDONE;

ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; EXERCISE; FORCED EXPIRATORY VOLUME; GENERAL PRACTITIONER; HEART FAILURE; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG VOLUME; MEDICAL SPECIALIST; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; SPIROMETRY; VITAL CAPACITY; COMPLICATION; EARLY DIAGNOSIS; LUNG DISEASES, INTERSTITIAL; PRIMARY HEALTH CARE;

DYSPNEA; EARLY DIAGNOSIS; HUMANS; LUNG DISEASES, INTERSTITIAL; PRIMARY HEALTH CARE;

EID: 84937066042     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2014.54     Document Type: Review

References (37)

1. American Thoracic Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304
2. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-972
3. Collard HR, Tino G, Noble PW, Shreve MA, Michaels M, Carlson B et al. Patient experiences with pulmonary fibrosis. Respir Med 2007; 101: 1350-1354
4. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748
5. Schwaiblmair M, Behr W, Haeckel T, Markl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. Open Respir Med J 2012; 6: 63-74
6. De Boer S, Wilsher M. Review series: aspects of interstitial lung disease. Sarcoidosis. Chron Respir Dis 2010; 7: 247-258
7. Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J et al. Rheumatoid arthritis-interstitial lung disease-Associated mortality. Am J Respir Crit Care Med 2011; 183: 372-378
8. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J 2013; 42: 750-757
9. Kim DS, Collard HR, King TE Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006; 3: 285-292
10. Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 2010; 35: 496-504
11. Lawson WE, Loyd JE. The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease? Proc Am Thorac Soc 2006; 3: 345-349
12. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824
13. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev 2012; 21: 355-361
14. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. (2014). http://www. goldcopd.org (accessed 11 May 2014).
15. Cottin V, Le PJ, Prevot G, Mal H, Humbert M, Simonneau G et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105-111
16. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968
17. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 183: 431-440
18. National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summary on breathlessness (2014). http://cks.nice.org.uk/breathlessness#! scenariorecommendation: 7 (accessed 11 May 2014).
19. Lynch DA, Travis WD, Muller NL, Galvin JR, Hansell DM, Grenier PA et al. Idiopathic interstitial pneumonias: CT features. Radiology 2005; 236: 10-21
20. Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am J Epidemiol 2000; 152: 307-315
21. Cottin V, Cordier JF. Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis? Eur Respir J 2012; 40: 519-521
22. Borchers AT, Chang C, Keen CL, Gershwin ME. Idiopathic pulmonary fibrosis-An epidemiological and pathological review. Clin Rev Allergy Immunol 2011; 40: 117-134
23. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63: v1-58
24. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-2092
25. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U t al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071-2082
26. Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-Acetylcysteine for pulmonary fibrosis. N Engl J Med 2012; 366: 1968-1977
27. Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C et al. A placebocontrolled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012; 186: 88-95
28. Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2093-2101
29. Soares RV, Forsythe A, Hogarth K, Sweiss NJ, Noth I, Patti MG. Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment. Arq Gastroenterol 2011; 48: 91-97
30. Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006; 27: 136-142
31. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 184: 1390-1394
32. Hallowell RW, Reed RM, Fraig M, Horton MR, Girgis RE. Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia. Pulm Circ 2012; 2: 101-106
33. Pitsiou G, Papakosta D, Bouros D. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration 2011; 82: 294-304.
34. Hubbard RB, Smith C, Le JI, Gribbin J, Fogarty AW. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med 2008; 178: 1257-1261.
35. Holland A, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev 2008; (4): CD006322.
36. Huppmann P, Sczepanski B, Boensch M, Winterkamp S, Sch'nheit-Kenn U, Neurohr C et al. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 2013; 42: 444-453.
37. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ et al. International guidelines for the selection of lung transplant candidates: 2006 update-A consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745-755.